Dermaregeon
International cosmetic brand of CK Regeon Inc. (Seoul, South Korea) — built on 20+ years of WNT/β-catenin regenerative-medicine research and the proprietary WNT ON Formula. Two brands: HERIBON for daily scalp ritual and HAIRREGEON for premium intensive treatment, anchored by the patented PTD-DBM Hair Booster. Already CPNP (EU), MoCRA (USA) and German Derma Excellent certified — actively expanding internationally from ASEAN.
Dermaregeon — CK Regeon Inc.
Dermaregeon is the international cosmetic brand of CK Regeon Inc., a South Korean biotechnology company founded in October 2016 and rooted in more than 20 years of academic research on the WNT signalling pathway — the master biological mechanism that regulates tissue regeneration in the human body. Headquartered inside the Yonsei Engineering Research Park in Seoul, CK Regeon has translated this regenerative-medicine expertise into two dedicated hair and scalp care brands, HERIBON and HAIRREGEON, both powered by the company's proprietary WNT ON Formula built around patented actives such as KY19382 (PTD-DBM) and Hesperidin.
The scientific premise is unusual for a cosmetics house: rather than formulating around cosmetic-grade ingredients, CK Regeon starts from regenerative biology — how the WNT/β-catenin pathway governs hair follicle cycling, scalp ageing and tissue renewal — and designs each formula to actively modulate that pathway. The result is a product portfolio positioned at the intersection of functional cosmetics and dermocosmetics: routine-driven, biologically targeted, and supported by internationally recognised regulatory readiness.
In 2025 CK Regeon launched its international expansion under the Dermaregeon umbrella, debuting HERIBON and HAIRREGEON at Cosmoprof CBE ASEAN Bangkok as a strategic entry point into the ASEAN and broader Asian markets. Products are already compliant with the EU Cosmetics Product Notification Portal (CPNP), the US Modernization of Cosmetics Regulation Act (MoCRA), and have received the German Derma Excellent certification — clearing the way for distribution partnerships across Europe, the Americas and the wider APAC region.
The dual-brand structure is intentional. HERIBON anchors the daily scalp ritual with a complete routine of shampoo, treatment, tonic and scalp scaler; HAIRREGEON sits above as the premium, intensive-care line for focused scalp management, including the flagship PTD-DBM Hair Booster — a concentrated, clinic-adjacent treatment for consumers and practitioners working on follicle regeneration outcomes.
What Dermaregeon brings to the table
20+ Years of WNT Pathway Research, Translated to Cosmetics
CK Regeon's scientific platform is built on more than two decades of research into the WNT/β-catenin signalling pathway — the master regulator of tissue regeneration. Rather than formulating around conventional cosmetic ingredients, the company designs each product to actively engage this biological mechanism, giving distributors a scientifically defensible story for hair and scalp care that goes well beyond typical 'anti-hair-loss' claims.
Proprietary WNT ON Formula with Patented Actives
The WNT ON Formula is the common scientific backbone across both HERIBON and HAIRREGEON. It centres on two patented actives: KY19382 (also known as PTD-DBM), the company's lead WNT-modulating molecule, and Hesperidin, a citrus-derived flavonoid known for vascular and antioxidant support of the scalp environment. The combination targets the biological root causes of hair loss and scalp ageing, not just their cosmetic symptoms.
HERIBON — Daily Scalp Ritual
HERIBON is the daily-care brand built around the WNT ON Formula: Shampoo for routine cleansing, Treatment for conditioning and scalp support, Tonic for leave-on scalp revitalisation, and a dedicated Scalp Scaler for periodic exfoliation. The line gives distributors a complete daily hair-and-scalp routine at a premium-but-accessible price point, suitable for pharmacies, salons and scalp-care studios.
HAIRREGEON — Premium Intensive Treatment
HAIRREGEON is the premium, intensive-care line for consumers and practitioners who need focused scalp management. Its flagship product, the PTD-DBM Hair Booster, delivers CK Regeon's lead molecule at clinical-grade concentration, designed for targeted follicle regeneration support. The line complements HERIBON and opens higher-margin retail and clinic channels for distributors targeting advanced hair-loss and trichology positioning.
International Regulatory Compliance Built In
Dermaregeon products are already compliant with the EU Cosmetics Product Notification Portal (CPNP), the US Modernization of Cosmetics Regulation Act (MoCRA), and carry the German Derma Excellent certification. International distributors do not need to fund a fresh regulatory pathway — the documentation and dossier structure is already in place to onboard into the EU, the US, and the wider DACH / German-speaking professional market.
Dermatological & Trichology Credibility
Founded and scientifically directed by Dr. Kang-Yell Choi, a leading researcher in WNT/β-catenin signalling and regenerative medicine. The brand combines academic publication pedigree with a commercial product line — a rare asset for distributors seeking hair-care partners with credible scientific backing rather than generic cosmetic claims.
Korean Beauty Heritage, International Distribution Ambition
Dermaregeon inherits the formulation rigour and aesthetic standards of the Korean beauty category while being structured for international rollout from launch. HERIBON packaging and sensory design match the premium K-Beauty codes that resonate with European hair-care consumers, while the regulatory dossier supports accelerated market entry in lieu of a long, brand-by-brand country build-up.
Active International Expansion Programme
In 2025 CK Regeon debuted at Cosmoprof CBE ASEAN Bangkok as the foundation of its international expansion roadmap, with ASEAN as the strategic entry point and broader APAC, Europe and the Americas in active scope. The brand is open to distribution, salon-network, pharmacy and spa-channel partnerships and is actively building the partnership infrastructure needed to scale beyond South Korea.
Why international buyers choose this brand
- Proprietary WNT ON Formula built on 20+ years of WNT/β-catenin regenerative-medicine research — a scientific platform, not just a cosmetic claim.
- Patented lead actives KY19382 (PTD-DBM) and Hesperidin, positioned to target the biological root causes of hair loss and scalp ageing.
- Dual-brand portfolio structure: HERIBON anchors a daily scalp ritual at mainstream premium price points; HAIRREGEON covers premium intensive and clinic-adjacent treatment.
- International regulatory compliance already in place — CPNP (EU), MoCRA (USA), German Derma Excellent — enabling accelerated onboarding for distributors.
- Scientific leadership by Dr. Kang-Yell Choi, a recognised researcher in WNT signalling and regenerative medicine — rare depth of academic credibility for a cosmetics brand.
- Korean beauty formulation heritage aligned with the sensory and design codes that resonate with European hair-care consumers.
- Active international expansion from 2025 — strategic debut at Cosmoprof CBE ASEAN Bangkok and clear roadmap for distribution partnerships across APAC, Europe and the Americas.
- Full routine architecture for both daily (Shampoo · Treatment · Tonic · Scalp Scaler) and intensive (PTD-DBM Hair Booster) channels, ready for pharmacy, salon, scalp-care and trichology distribution.
International distribution & partnership programme
CK Regeon Inc. is actively building international distribution for HERIBON and HAIRREGEON under the Dermaregeon umbrella, with a strategic entry point in ASEAN following its debut at Cosmoprof CBE ASEAN Bangkok 2025. The brand is open to engaging with distributors, importers, pharmacy groups, scalp-care studios, trichology clinics and spa networks across Europe, the Americas, the Middle East and the wider APAC region. International regulatory readiness (CPNP EU, MoCRA USA, German Derma Excellent) is already in place to accelerate onboarding in priority markets.